Besides, reduced appetite, anorexia and altered intestinal motility often accompany intestinal inflammation, and might be linked to EEC, since PYY, GLP-1, and CCK signal satiety and modify motility (163, 164)
Nausea, Vomiting & Acid Reflux GLP1s slow stomach emptying, which may cause reflux or vomiting
The safety profile of cagrilintide-semaglutide was broadly consistent with that reported for other incretin-based therapies, although gastrointestinal adverse events and treatment discontinuations occurred more frequently than with either semaglutide or cagrilintide alone, highlighting the importance of careful patient selection and long-term adherence
Dipeptidyl Peptidase IV Inhibition Downregulates Na+ - H+ Exchanger NHE3 in Rat Renal Proximal Tubule
Cloudiness indicates either bacterial contamination or peptide aggregation (clumping), both of which render the solution unsafe and ineffective
Both medications suppress appetite through different mechanisms, which may lead to inadequate nutrition and require monitoring of dietary intake and weight loss rate